Trevena Analysis
TRVNDelisted Stock | USD 1.98 0.18 10.00% |
Trevena is overvalued with Real Value of 1.88 and Hype Value of 1.66. The main objective of Trevena delisted stock analysis is to determine its intrinsic value, which is an estimate of what Trevena is worth, separate from its market price. There are two main types of Trevena's stock analysis: fundamental analysis and technical analysis.
The Trevena stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Trevena is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Trevena Stock trading window is adjusted to America/New York timezone.
Trevena |
Trevena Stock Analysis Notes
The company has price-to-book ratio of 0.36. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Trevena recorded a loss per share of 56.5. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 13th of August 2024. Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania. Trevena operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people. To find out more about Trevena contact the company at 610 354 8840 or learn more at https://www.trevena.com.Trevena Investment Alerts
Trevena is not yet fully synchronised with the market data | |
Trevena generated a negative expected return over the last 90 days | |
Trevena has high historical volatility and very poor performance | |
Trevena may become a speculative penny stock | |
Trevena has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 3.12 M. Net Loss for the year was (40.29 M) with loss before overhead, payroll, taxes, and interest of (3.44 M). | |
Trevena currently holds about 49.52 M in cash with (33.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. |
Trevena Upcoming and Recent Events
Earnings reports are used by Trevena to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
4th of April 2024 Upcoming Quarterly Report | View | |
20th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
4th of April 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Trevena Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.13 M.Trevena Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Trevena insiders, such as employees or executives, is commonly permitted as long as it does not rely on Trevena's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Trevena insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Trevena Outstanding Bonds
Trevena issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Trevena uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Trevena bonds can be classified according to their maturity, which is the date when Trevena has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Trevena Predictive Daily Indicators
Trevena intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Trevena stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Trevena Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Trevena prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Trevena shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Trevena. By using and applying Trevena Stock analysis, traders can create a robust methodology for identifying Trevena entry and exit points for their positions.
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania. Trevena operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Trevena to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
All Next | Launch Module |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Trevena Stock
If you are still planning to invest in Trevena check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Trevena's history and understand the potential risks before investing.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |